Skip to main content

Search

Reset all filters
112 Result(s)
Sort by

Innovation in Oncology and Cancer Immunology Research

Innovation in Oncology and Cancer Immunology Research

We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Mental Health

Mental Health

Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
Our Commitment

Our Commitment

Humanity faces great challenges. We believe that we can always do more - for ourselves and for future generations.
Health, Safety & Environment

Health, Safety & Environment

Suppliers aim to ensure a safe and healthy working environment and to act in an ecological and sustainable manner.
Access to Care platform

Access to Care platform

Discover how Boehringer Ingelheim is addressing health equity and healthcare access in Central and Eastern Europe through the "Access to Care" platform. Learn about the Legal Toolkit designed for patient advocates and the impact of our initiatives in the
Innovation through Collaboration

Innovation through Collaboration

Pharmaceutical manufacturers and healthcare professionals regularly interact to learn from each other and improve patient care.
More Potential: Overview

More Potential: Overview

Society continues to face challenges ranging from health to education, work prospects, living conditions, inequalities and poverty, often impacting vulnerable communities the most.
Testing New Treatments for NF1

Testing New Treatments for NF1

The Medical University of Vienna and Boehringer Ingelheim have taken an innovative approach to the development of ways of treating NF1-associated tumors.